Tesamorelin
A modified GHRH analog best known in clinical research for its effects on visceral fat and growth hormone signaling. Tesamorelin is studied for its role in body composition, IGF-1 levels, and metabolic research.
The GHRH analog built for body composition.
Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH), modified with a stabilizing group that extends its resistance to enzymatic degradation well beyond that of native GHRH or earlier analogs like Sermorelin. It works upstream of growth hormone itself, signaling the pituitary to release GH through the body’s natural pulsatile rhythm.
Body composition shifts as women age often outpace what diet and exercise alone can explain — visceral fat accumulates in ways that reflect changes in the growth hormone axis as much as lifestyle. Tesamorelin’s research base speaks directly to that intersection.
Published research has documented Tesamorelin’s effects on reducing visceral adipose tissue, increasing IGF-1 levels, supporting lean body mass, and its studied role in body composition and metabolic research. It carries one of the more robust clinical research bases of any GHRH analog in current use.
Where the GH axis meets metabolism.
Visceral Fat Research
Growth Hormone Axis Support
Body Composition & IGF-1 Research
